Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 77

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 1
Chunk 77
---
 Company issued an aggregate of 75,000 shares of common stock pursuant to the ATM
Agreement for net proceeds of $838,390. The Company paid the sales agent compensation with respect to sale of such shares in the amount
of $25,935. 

Facility and Amended Facility Agreement

On August 4, 2025 (the “Original Agreement
Date”), the Company entered into the Equity Purchase Facility Agreement (“Existing Facility Agreement”) with an institutional
investor (“Facility Investor”), pursuant to which the Facility Investor committed to purchase, subject to certain conditions
and limitations, up to $150,000,000 (the “Commitment Amount”) in newly issued shares of the common stock of the Company (the
“Facility”). In connection with the Facility, on the Original Agreement Date the Company entered into a Registration Rights
Agreement (the “Existing RRA”) with the Facility Investor.

Pursuant to the terms of the Existing Facility
Agreement, the issuance of shares of common stock in excess of 19.99% of the Company’s outstanding shares of common stock was conditional
upon obtaining the approval of the Company’s stockholders in accordance with the rules and regulations of the Nasdaq Capital Market.
On August 6, 2025, the stockholders, holding approximately 96.3% of the votes of our outstanding voting stock approved the Existing Facility
Agreement and Existing RRA, including, but not limited to the issuance of the shares of common stock in excess of 19.99% of the Company’s
issued and outstanding common stock at a price less than the minimum price required by the Nasdaq Capital Market, in compliance with the
rules and regulations of the Nasdaq Capital Market. On August 8, 2025, the Company filed a preliminary information statement on Schedule
14C with the SEC notifying stockholders of such approval. The Company filed a definitive information statement on Schedule 14C with the
SEC and commenced mailing of the definitive information statement to stockholders of record on August 18, 2025. Such stockholders’
approval became effective on September 7, 2025. In accordance with the terms of the Existing RRA, on August 11, 2025, the Company filed
with the SEC a Registration Statement on Form S-1 (Reg. No. 333-289503) to register up to 100,000,000 shares of common stock issuable
pursuant to the Existing Facility